Invention Grant
- Patent Title: Methods for increasing sepiapterin plasma exposure
-
Application No.: US17059719Application Date: 2019-05-30
-
Publication No.: US11617752B2Publication Date: 2023-04-04
- Inventor: Neil Smith , Jonathan Reis
- Applicant: PTC Therapeutics MP, Inc.
- Applicant Address: US NJ South Plainfield
- Assignee: PTC Therapeutics MP, Inc.
- Current Assignee: PTC Therapeutics MP, Inc.
- Current Assignee Address: US NJ South Plainfield
- Agency: Clark & Elbing LLP
- International Application: PCT/US2019/034523 WO 20190530
- International Announcement: WO2019/232130 WO 20191205
- Main IPC: A61K31/519
- IPC: A61K31/519 ; A61K9/00
Abstract:
The present invention features compositions including sepiapterin, or a pharmaceutically acceptable salt thereof, and methods for the treatment of BH4-related disorders. In some embodiments, these compositions and methods result in an increase in plasma, CSF, and/or brain exposure of sepiapterin.
Public/Granted literature
- US20210220363A1 METHODS FOR INCREASING SEPIAPTERIN PLASMA EXPOSURE Public/Granted day:2021-07-22
Information query
IPC分类:
